Sumco Slid To Loss In FY25; Guides Q1

Sumco reported a full-year net loss attributable to owners of ¥11.75 billion versus a ¥19.88 billion profit a year earlier, with basic loss per share of ¥33.60 (prior EPS ¥56.84), despite revenue rising to ¥409.67 billion from ¥396.62 billion. Operating profit plunged to ¥1.34 billion from ¥36.92 billion; management guided Q1 FY2026 sales of ¥100 billion, an operating loss of ¥6 billion, and surprisingly forecast profit attributable to owners of ¥10 billion while expecting a basic loss per share of ¥28.59. The combination of deteriorating profitability and weak near-term operating guidance makes the report negative for fundamentals even as the stock closed up 4.13% at ¥1,764.50.

Analysis

Market structure: Sumco's FY results (¥11.75bn net loss vs prior ¥19.88bn profit, sales ¥409.7bn up) signal margin compression not demand collapse — wafer volumes likely held but mix, pricing or cost inflation (energy/polysilicon) hit profitability. Direct losers: pure-play wafer suppliers (3436.T) and smaller niche makers with weaker balance sheets; winners are diversified chemical/materials players (e.g., 4063.T Shin‑Etsu) and large fabs that can negotiate price or benefit from cheaper wafer spot pricing. Cross-asset: expect a rise in SUMCO credit spread and equity implied volatility; JPY moves limited but risk-off could boost JPY and Japanese sovereign yields marginally; semiconductor equipment equities (ASML, 8035.T) less immediately impacted.

Risk assessment: key tail risks include a hidden one-off impairment or inventory write-down (guidance inconsistency: projected Q1 operating loss ¥6bn vs ¥10bn profit attributable flagging accounting noise), major customer order cancellations (TSMC/Samsung exposure), or a plant outage causing multi-quarter disruptions. Time horizons: immediate (days) — elevated IV and possible knee-jerk price moves; short-term (1–3 months) — Q1 execution and clarification of the guidance anomaly; long-term (12–24 months) — wafer cycle recovery tied to foundry capex for advanced nodes. Monitor receivables, inventory days, and any extraordinary items disclosed within 30 days as catalysts.

Trade implications: tactical short bias on SUMCO (3436.T) given compressed margins and murky guidance — prefer defined-risk put spreads over outright short to limit tail risk; overweight diversified materials (4063.T) or equipment makers (8035.T/ASML) on relative strength. Pair trade: go long Shin‑Etsu (4063.T) and short Sumco (3436.T) equal notional for 3–6 months to capture spread if consolidation/price negotiation favors larger integrators. Options: buy 3‑month SUMCO put spread (e.g., buy 1750/ sell 1400) sized to 1–3% portfolio risk; hedge with small long-call position if downside reverses.

Contrarian angles: consensus may over-penalize Sumco — sales growth with profit loss suggests one-off or temporary margin hit rather than structural demand collapse; historical wafer downturns rebounded within 6–12 months once fab ordering resumed. Reaction could be overdone if guidance contains accounting quirks; downside capped if company announces cost cuts, asset sales, or customer prepayments. Maintain small position sizes and a 10% stop on outright shorts; consider event-driven long risk if Q1 disclosures clarify non-recurring items.

Key Decisions for Investors

• Initiate a defined-risk short on Sumco (3436.T): buy 3‑month put spread with strikes ~¥1,760/¥1,400 (cost-limited), sizing to 1–2% portfolio risk, target 20% downside within 3 months, stop-loss: close if price rises >10% from entry or if company issues credible turnaround/capital action within 30 days.
• Establish a 1–2% long position in Shin‑Etsu Chemical (4063.T) versus an equal notional short in Sumco (3436.T) as a 3–6 month pair trade to capture relative margin resilience; rebalance if spread narrows <5% or if Shin‑Etsu shows deterioration in order flow.
• For conservative investors, reduce semiconductor materials exposure by 1–3% and reallocate to equipment makers (ASML, 8035.T) with a 3–12 month horizon, expecting earlier recovery in capex; trim further if wafer suppliers report additional negative guidance at Q1.
• Monitor three specific 30‑day triggers before adding risk: (1) Sumco’s Q1 detail on extraordinary items/inventory write-downs, (2) customer order trends/consignment inventory disclosures, and (3) any capital actions (asset sale, rights issue). If all three are benign, convert put-spread to a delta-hedged short equity position.